Abstract

The "Lists": What Do They Mean?

Author(s): Voliva John

Issue: Nov/Dec 2016 - Volume 20, Number 6

View All Articles in Issue

Page(s): 477-479

Download in electronic PDF format for $75

Abstract

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Nov/Dec 2016 Pg. 477-479	The "Lists": What Do They Mean? Author(s): Voliva John
Nov/Dec 2016 Pg. 457-458	U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List) Author(s):
Jul/Aug 2015 Pg. 311-313	Basics of Compounding: The "Negative" List Author(s): Allen Loyd V
Jan/Feb 2015 Pg. 57-58	Basics of Compounding: The Revised "Not to Compound List" Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 208	The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter Author(s): Miller David G
Jan/Feb 2005 Pg. 44-46	The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List") Author(s): Allen Loyd V Jr, Ashworth Lisa D
Sep/Oct 2021 Pg. 358-362	Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Author(s): Cabaleiro Joe
Nov/Dec 2015 Pg. 487-488	U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 389-390	Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 379-380	Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Author(s): Blankenship Cynthia E
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2017 Pg. 95-102	U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Author(s): Yoch Doug
Jul/Aug 2016 Pg. 351 View Sample	Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 356	PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 116-117	The International Academy of Compounding Pharmacists Introduces a New President Author(s): Rice Baylor
Jul/Aug 2015 Pg. 303-305	U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Author(s): Miller David G
Mar/Apr 2016 Pg. 95-96	Legislative/Regulatory Update: From the International Academy of Compounding Pharmacists: Appropriations Author(s): McCrory Gary
Jan/Feb 2025 Pg. 22-27	Best Practices When Compounding FDA-Approved Drugs Listed in Shortage Author(s): Alliance for Pharmacy Compounding
Mar/Apr 2014 Pg. 117-118	IACP's Continuing Support of Compounding Pharmacists: Letter to the FDA Concerning 503B Outsourcing Facilities Author(s): Miller David G
Sep/Oct 2015 Pg. 375	The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding Author(s): Miller David G